UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 22, 2001
BIOJECT MEDICAL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Oregon 0-15360 93-1099680
(State or other jurisdiction of (Commission (IRS Employer
incorporation) File Number) Identification No.)
7620 S.W. Bridgeport Road, Portland, OR 97224
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (503) 639-7221
No Change
(Former name or former address, if changed since last report)
Item 5. Other Events
Attached to this Form 8-K as Exhibit 99.1 and incorporated into this Form
8-K by reference is the company's press release dated May 22, 2001 announcing
its fiscal 2001 financial results.
Item 7. Financial Statements and Exhibits
(c) Exhibits.
--------
99.1 Press release dated May 22, 2001.
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: May 22, 2001.
BIOJECT MEDICAL TECHNOLOGIES, INC.
By: /s/ Christine M. Farrell
-------------------------
Christine M. Farrell
Controller and Secretary
2
EXHIBIT INDEX
Exhibit Description
- ------- -----------
99.1 Press release dated May 22, 2001.